Recent Blog Articles
Harvard Health Ad Watch: Can a wearable device reduce stress?
Listening to your hunger cues
Does your child need to bathe every day?
Can flavonoids help fend off forgetfulness?
Can physical or cognitive activity prevent dementia?
Wondering how much your medical care will cost? New rules could help
Long-lasting healthy changes: Doable and worthwhile
The sore throat checklist: What parents need to know
A new treatment for obesity
Remember the flu? Yep, it's that time again
Harvard Health Blog Experts
List of Experts
Robert C. Meisner, MD
Robert C. Meisner, MD, is the medical director of the ketamine service in the psychiatric neurotherapeutics program at McLean Hospital, and an attending psychiatrist in the acute psychiatric service at Massachusetts General Hospital. He graduated from Princeton summa cum laude and attended Harvard Medical School. He was a doctoral student in cultural anthropology at the Harvard Graduate School for Arts and Sciences, where he focused on child soldiering in Uganda under American anthropologist Arthur Kleinman. He received his early clinical training as a resident at Harvard in internal medicine, anesthesia, critical care, and pain. Dr. Meisner has written and lectured on a wide range of topics, from pediatric and collegiate mood disorders to the safe translation of ketamine research into evidence-based clinical practice. He has previously served on the administrative board of Harvard College, as acting resident dean at Harvard College’s Currier House, and on the faculty of arts and sciences at Harvard University.
Elizabeth Bashoff, MD
Elizabeth Bashoff, MD, is an Endocrinologist and Senior Physician in the Adult Diabetes section at the Joslin Diabetes Center, an Attending Physician at Beth Israel Deaconess Medical Center, and an Instructor in Medicine at Harvard Medical School. She serves as Medical Director of the Joslin Clinic Diabetes Outpatient Intensive Treatment (DO IT) program, a specialized team approach for people whose diabetes requires extended attention and evaluation. Dr. Bashoff teaches clinical diabetes skills to medical students, residents, and fellows, and is a member of the OSCE Core Faculty at Harvard Medical School.
Salim Zerriny, MD
Salim Zerriny, MD is a 3rd-year resident, currently training at Brigham and Women’s Hospital Anesthesiology Program. He has a special interest in pain and healthcare innovation.
David Boyce, MD
Dr. David Boyce is board-certified in general anesthesiology and pain medicine. After graduating from Tufts University School of Medicine, he completed his residency and a pain medicine fellowship at Brigham and Women’s Hospital in Boston. He is currently an Instructor in Anesthesiology at HMS and the anesthesiologist-in-charge of the main operating room at Brigham and Women’s Hospital, where he also attends on the in-patient Chronic Pain Service. Dr. Boyce provides care for patients in an outpatient pain clinic and he has given regional and national talks on back pain, including hands-on ultrasound workshops for the International Association for the Study of Pain (IASP). His clinical interests include safer surgery and non-opioid alternatives to managing chronic pain.
Andrew E. Budson, MD
Website: Andrew Budson, MD
Facebook: Andrew Budson, MD
Aneesh Singhal, MD
Aneesh B. Singhal, MD, is Vice-Chair of Neurology Quality and Safety at Massachusetts General Hospital and Associate Professor of Neurology at Harvard Medical School in Boston, USA. He is a Board Certified Neurologist, Vascular Neurologist and, Neurosonologist. He serves on the Board of Trustees of the Partners Continuing Care and Spaulding Rehabilitation Network, is advisor to Partners HealthCare International and Neurology Foundation India. He is an elected Fellow to the American Neurological Association, the American Academy of Neurology, and the American Heart Association, and Past President of the Association of Indian Neurologists in USA.
Dr. Singhal’s areas of research include stroke clinical trials, stroke in young adults, cerebral arteriopathies, advanced brain imaging for acute ischemic stroke, and stroke neuroprotection. He is internationally recognized for his work on characterizing the reversible cerebral vasoconstriction syndrome (RCVS) and cerebral vasculitis. He is Deputy Principal Investigator of the New England Regional Coordinating Center (NERCC) for the NIH StrokeNet. He has served as the Principal Investigator of the NIH funded Indo-US Collaborative Stroke Project, the NIH funded Phase 2 trial of Normobaric Oxygen Therapy in Acute Stroke, and as site PI of several Industry funded stroke clinical trials. Dr. Singhal has authored or co-authored over 200 articles and book chapters.
Andrew Chan, MD, MPH
Andrew T. Chan, MD, MPH is a Professor of Medicine at Harvard Medical School (HMS), Chief of the Clinical and Translational Epidemiology Unit, and the Program Director for gastroenterology training at Massachusetts General Hospital (MGH). As a clinical gastroenterologist, Dr. Chan specializes in familial gastrointestinal cancer syndromes and cancer prevention. Dr. Chan is a leading investigator in the epidemiology of colorectal cancer and other digestive diseases, with a focus on chemoprevention with aspirin and the interaction of diet with the gut microbiome. An elected fellow of the American Society of Clinical Investigation, he currently supported by NCI, NIDDK, and the Crohn’s and Colitis Foundation for his research. He has published over 400 papers in the field of colorectal cancer and other chronic digestive diseases in leading journals, including the New England Journal of Medicine, Journal of the American Medical Association, Lancet, Science Translational Medicine, Gastroenterology and Gut. Dr Chan is a section editor for Gastroenterology, serves on the editorial board of Cancer Prevention Research and Cancer Epidemiology Biomarkers and Prevention, and is vice-chair of the Gastrointestinal Oncology Section of the AGA.
Emily Gelsomin, MLA, RD, LDN
Emily Gelsomin, MLA, RD, LDN, is a senior clinical nutrition specialist at Massachusetts General Hospital (MGH). As a registered dietitian, she counsels on medical nutrition therapy on an outpatient basis and is the co-director of Be Fit, the hospital’s employee wellness program. She has a Bachelor of Nutritional Science from Pennsylvania State University and a Master of Liberal Arts in Gastronomy from Boston University. She has worked at MGH since 2005 and helped develop Choose Well Eat Well, a traffic-light labeling system designed to promote healthier choices in MGH’s cafeterias. Emily enjoys freelance food writing and has received the Julia Child Award in Scholarship Excellence. She is passionate about improving our societal relationship with food and is an avid home cook.
Shafik Boyaji, MD
Dr. Boyaji earned his medical degree from University of Aleppo, Syria. He completed an Internal Medicine residency at Michigan State University and an Anesthesiology residency at the Brigham and Women’s Hospital. Currently he is in fellowship for Interventional Pain Management. He has a special interest in non-opioid pain management modalities, including neuromodulation for pain.
May Wakamatsu, MD
May Wakamatsu, MD, joined Mass General Hospital in 1990. She trained in Urogynecology (now called Female Pelvic Medicine & Reconstructive Surgery) under the guidance of the late David Nichols, MD. She is board certified in Female Pelvic Medicine & Reconstructive Surgery.
Dr. Wakamatsu evaluates and treat patients with complex pelvic floor disorders including urinary incontinence, pelvic organ prolapse, which can include uterine prolapse, vaginal vault prolapse, anterior vaginal wall prolapse (cystocele) and posterior vaginal wall prolapse (rectocele). She also sees patients with mesh-related complications (mesh erosion, mesh exposure), urogenital fistula and other pelvic floor issues.
Dr. Wakamatsu is a member of the Mass General Pelvic Floor Disorders Service, a multidisciplinary group comprised of pelvic reconstructive surgeons, colorectal surgeons, urologists, gastroenterologists and physical therapists. The service provides surgical and nonsurgical treatment options, including minimally-invasive surgeries such as vaginal, laparoscopic and/or robotic assisted surgeries. She holds regular conferences to discuss patients with complex and combined pelvic floor disorders.
Ilona T. Goldfarb, MD, MPH
Ilona Goldfarb, MD, MPH, is a board-certified maternal fetal medicine specialist at the Massachusetts General Hospital (MGH). She completed medical school and residency in California and a fellowship at MGH. Her areas of interest and expertise include public health, perinatal infectious diseases, and quality improvement in obstetrical care. She spends the majority of her time providing direct prenatal, delivery, and postpartum care to women with high-risk maternal or fetal conditions. In this capacity, she provides consultation on high-risk pregnancy patients across New England. In addition to patient care, Dr. Goldfarb is actively engaged in teaching medical students as the OB/GYN associate clerkship director for Harvard Medical School, directing clinical research projects with students, residents, and fellows, and participating on department as well as hospital-wide committees. She is also an avid theatergoer and mom to two wonderful teenagers.
David M. Slovik, MD
David M. Slovik, MD, is an endocrinologist at Massachusetts General Hospital (MGH) who specializes in osteoporosis, and an associate professor of medicine at Harvard Medical School. He is currently chief of the division of endocrinology at Newton-Wellesley Hospital, and former chief of medicine at Spaulding Rehabilitation Hospital. Dr. Slovik did his internship in internal medicine at New York Hospital-Cornell Medical Center, and then went into the Indian Health Service for two years. He then came to Boston to complete his internal medicine residency and endocrine fellowship at MGH, and has remained on staff there in endocrine practice for over 40 years. Since 1991, Dr. Slovik has acted as the medical editor for Osteoporosis: A Guide to Prevention and Treatment, a Harvard Health Publishing Special Health Report.
Florencia Halperin, MD
Florencia Halperin, MD, is the co-founder and Co-Director of the Center for Weight Management and Metabolic Surgery at Brigham and Women’s Hospital, and Chief of Endocrinology at Brigham and Women’s Faulkner Hospital. Her clinical research is focused on the delivery of weight loss interventions, as well as on the metabolic effects of bariatric surgery. Her clinical research is complemented by her clinical practice focused on the management of obesity and diabetes.
James Yeh, MD, MPH
James Song-Jeng Yeh, MD, MPH, practices internal medicine at Massachusetts General Hospital and is an instructor in medicine at Harvard Medical School, where he actively teaches medical students and residents.
His clinical interests and expertise are evidence-based medicine, cardiopulmonary diseases, cardiovascular risk reduction, critical illness, care transition, medication adherence, polypharmacy, health communication, and medical education.
Dr. Yeh completed his medical training at Harvard Medical School teaching hospitals with internal medicine residency and fellowship at Cambridge Hospital and Brigham and Women’s Hospital. During fellowship, he conducted research in the field of pharmacoepidemiology with focus on evidence-based medicine, conflict of interest, academic detailing/educational outreach, and medication safety/boxed warning. Dr. Yeh also completed an editorial fellowship at the New England Journal of Medicine. He has published in various academic journals including the New England Journal of Medicine, JAMA Internal Medicine, and the Journal of Graduate Medical Education.
Dr. Yeh’s clinical work involves both ambulatory and in-patient medicine with focuses on providing care to patients with general primary care issues to those with complex medical illness including chronic critically ill patients on chronic ventilation, ventricular assist devices, recent lung, liver, and heart transplant patients, oncology and bone marrow transplant patients, and patients with disorder of consciousness/stroke patients. He is also a team physician for the New England Revolution.
Jeffrey Garber, MD, FACP, MACE
Jeffrey R. Garber, MD, FACP, MACE is an associate professor of medicine at Harvard Medical School, Chief of the Division of Endocrinology at Atrius Health , and member of the endocrine divisions of Beth Israel Deaconess Medical Center and the Brigham and Women’s Hospital in Boston, Massachusetts. Dr. Garber is a past President of the American Association of Clinical Endocrinologists and the American College of Endocrinology. He is the medical editor of the Harvard Medical School Special Health report on Thyroid Disease: Understanding hypothyroidism and hyperthyroidism.
Peter Gonzalez, MD
Peter Gonzalez, MD, is a clinician and educator in the Division of General Internal Medicine and Primary Care at Brigham and Women’s Hospital and is an Assistant Professor of Medicine at Harvard Medical School.
Cecil R. Webster, Jr., MD
Cecil R. Webster, Jr., MD is a child, adolescent, and adult psychiatrist in Boston. He is a lecturer in psychiatry at McLean Hospital and Harvard Medical School, and consultant for diversity health outreach programs at the Massachusetts Institute of Technology. In addition, Dr. Webster is a candidate in child and adult psychoanalysis at the Boston Psychoanalytic Society & Institute. His areas of expertise include identity formation and related influences such as sexuality, gender, race, ethnicity, and inter-cultural experiences in psychotherapy. He enjoys the intersection of film and psychiatry, applying psychoanalytic techniques in understanding portrayals of mental illness in film.
George King, MD
George L. King, M.D., is the Senior Vice President, Chief Scientific Officer at Joslin Diabetes Center, as well as a Professor of Medicine and Ophthalmology at Harvard Medical School. He received his medical degree from Duke University School of Medicine and residency at the University of Washington Affiliated Hospitals in Seattle and the National Institutes of Health. Dr. King has published over 300 papers and multiple books. Dr. King’s work focuses on finding the causes of diabetic complications, founder of The Medalist Study to discover new treatments for diabetic complications, and understanding the reasons for the high rate of diabetes in Asian Americans. His laboratory discovered that VEGF, protein most responsible for causing the severe form of diabetic eye disease. Dr. King has received numerous awards, Cogan Award from the Association for Research in Vision and Ophthalmology, Alcon Award for Vision Research, Harold Amos Diversity Award from Harvard Medical School, the Chinese American Medical Society Scientific Award, the 2015 Edwin Bierman Award from the American Diabetes Association, with several others, the Champalimaud Award for Vision, the largest award in the vison research field and Mary Tyler Moore and Robert Levine Award from the JDRF 2016.
Marc Gregory Yu, MD
Marc Gregory Y. Yu, MD is an American Diabetes Association (ADA) research fellow in the Section of Vascular Cell Biology at Joslin Diabetes Center. He finished medical school at the top of his class at the University of the Philippines-Philippine General Hospital, and completed residency in internal medicine and fellowship in endocrinology at the same institution thereafter. He is the first Filipino endocrinologist to receive the Endocrine Society Early Investigator Award in 2017. His main research interests include studying risk and protective factors for cardiovascular disease in patients with long-standing Type 1 diabetes, as well as looking at the interplay of autoimmunity, rare diabetes genes, and pancreatic beta-cell function. He is also co-author of I.M. Platinum, a bestselling Philippine handbook on Internal Medicine.
Chirag Patel, PhD
Chirag Patel, PhD, is an Assistant Professor in the Department of Biomedical Informatics at Harvard Medical School. His long-term research goal is to address problems in human health and disease by developing computational and informatics methods to reason over both genomic, metagenomic, and exposomic information, spanning molecules to populations toward more precise medicine, specifically type 2 diabetes and cardiovascular disease. Dr. Patel received his graduate degrees in biomedical informatics (MS, PhD) from Stanford University.
Alice Maxfield, MD
Alice Maxfield, MD, is an otolaryngologist with specialization in sinus and endoscopic skull base surgery at Brigham and Women’s Hospital. She is an instructor at Harvard Medical School and the BWH residency program director of the Harvard Otolaryngology Residency Program. Her clinical and research interests include sinus disease and outcomes of sinonasal surgery.
Janelle Nassim, MD
Janelle Nassim, MD, is a dermatology resident in the Harvard Combined Dermatology Residency Training Program. Her clinical interests are acne, laser and cosmetic dermatology, diet and dermatology, and accessibility and inclusion for patients with disabilities.
Katherine Dudley, MD, MPH
Katherine Dudley MD, MPH, is the Ambulatory Director of the Mount Auburn Hospital Pulmonary Consultants, and an instructor at Harvard Medical School. Her clinical passion lies in sleep medicine, particularly improving care delivery to reduce sleep related health disparities. She has a research background focusing on sleep patterns among minority populations and racial differences in sleep apnea management.
Dara K. Lee Lewis, MD
Dara Lee Lewis, MD, is a full-time cardiologist, director of imaging, and co-director of the Women’s Program at the Lown Cardiovascular Center. Her clinical interests include cardiac physiology, echocardiography, and heart disease in women. She is an associate physician at Brigham and Women’s Hospital. She also co-directs, teaches, and develops curriculum for the first-year Harvard Medical School cardiology, physiology, and pathophysiology course. Dr. Lee Lewis earned her medical degree from Harvard Medical School and completed her residency in internal medicine and fellowship in cardiology at Brigham and Women’s Hospital.
Robert Goldstein, MD, PhD
Dr. Robert Goldstein (he/him/his) is an instructor in Medicine at Harvard Medical School and serves as the medical director of the Transgender Health Program at Massachusetts General Hospital. Dr. Goldstein received his undergraduate degree, MD, and PhD at Tufts University before coming to MGH for internship, residency, and chief residency. He completed the combined MGH/BWH infectious disease fellowship in the HIV clinician educator track, and joined the faculty in 2018 as an infectious disease physician and primary care provider in the Transgender Health Program. His clinical practice is focused on caring for the LGBTQ community, those living with HIV, and those at risk for HIV.